You searched for Shefali Luthra - California Healthline

KFF Health News' 'What the Health?': The Walz Record

August 8, 2024

Vice President Kamala Harris this week officially became the Democratic nominee for president and named Minnesota governor and former U.S. congressman Tim Walz as her running mate. Meanwhile, a new study finds the number of abortions taking place since the overturn of “Roe v. Wade” continued to rise into early this year, despite the imposition of abortion bans around the country. Sandhya Raman of CQ Roll Call and Shefali Luthra of The 19th join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more.

KFF Health News' 'What the Health?': The Campaign’s Final Days

October 31, 2024

It’s the final days of the 2024 campaign, and Republicans are suddenly talking again about making changes to the Affordable Care Act if former President Donald Trump wins. Meanwhile, new reporting uncovers more maternal deaths under state abortion bans — and a case in which a Nevada woman was jailed after a miscarriage. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KFF Health News’ Emmarie Huetteman to discuss these stories and more. Also this week, KFF Health News’ Julie Rovner interviews Irving Washington, a senior vice president at KFF and the executive director of its Health Misinformation and Trust Initiative.

KFF Health News' 'What the Health?': Anti-Abortion Hard-Liners Speak Up

May 23, 2024

While Republican candidates in many states downplay their opposition to abortion, the most vehement wing of the movement, which helped overturn Roe v. Wade — those who advocate prosecuting patients, outlawing contraception, and banning IVF — are increasingly outspoken. Meanwhile, some state legislatures continue to advance new restrictions, like a proposal moving in Louisiana to include abortion medications mifepristone and misoprostol on the list of the most dangerous drugs. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins schools of public health and nursing and Politico Magazine join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Shefali Luthra of The 19th about her new book on abortion in post-Roe America, “Undue Burden.”

KFF Health News' 'What the Health?': Yet Another Promise for Long-Term Care Coverage

October 10, 2024

As part of her presidential campaign, Vice President Kamala Harris has rolled out a plan for Medicare to provide in-home long-term care services. The proposal would fill a longtime need for families trying to simultaneously care for young children and older parents, but its enormous price tag makes it a promise unlikely to be fulfilled. Meanwhile, a growing number of Republican candidates up and down the ballot facing voter backlash over their support for abortion restrictions are trying to reinvent their positions. Shefali Luthra of The 19th, Jessie Hellmann of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, excerpts from a KFF lunch with “Shark Tank” panelist and generic drug discounter Mark Cuban, who has been consulting with the Harris campaign about health care issues.

KFF Health News' 'What the Health?': American Health Under Trump — Past, Present, and Future

September 19, 2024

Dreaming of a Trump victory, Republicans have a wish list of health policy changes — including loosening Affordable Care Act regulations to make cheaper coverage available and ending Medicare drug price negotiations. Meanwhile, after a publicly reported death stemming from a state abortion ban, Vice President Kamala Harris is emphasizing the consequences of Trump’s work to overturn Roe v. Wade. Tami Luhby of CNN, Shefali Luthra of The 19th, and Joanne Kenen of Politico and Johns Hopkins University join KFF Health News senior editor Emmarie Huetteman to discuss these stories and more.

KFF Health News' 'What the Health?': New Year, Same Abortion Debate

January 4, 2024

Some Supreme Court justices were wrong if they assumed overturning “Roe v. Wade” would settle the abortion issue before the high court. At least two cases are awaiting consideration, and more are in the legal pipeline. Meanwhile, Congress once again has only days until the next temporary spending bill runs out, with no budget deal in sight. Lauren Weber of The Washington Post, Shefali Luthra of The 19th, and Victoria Knight of Axios join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Sandro Galea, dean of the Boston University School of Public Health, about how public health can regain public trust.

KFF Health News' 'What the Health?': Let the General Election Commence

August 23, 2024

Abortion and reproductive health issues headlined the Democratic National Convention in Chicago, as expected. But what Vice President Kamala Harris has in mind for other health policies as the Democratic nominee remains something of a mystery. Meanwhile, former President Donald Trump says he would not use the 19th-century Comstock Act to impose, in effect, a national ban on abortion, which angered his anti-abortion backers. Alice Miranda Ollstein of Politico, Joanne Kenen of Politico and Johns Hopkins University, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF Health News’ Tony Leys, who reported and wrote the latest KFF Health News-NPR “Bill of the Month” feature about a woman who fought back after being charged for two surgeries despite undergoing only one.

KFF Health News' 'What the Health?': GOP Platform Muddies Abortion Waters

July 11, 2024

As Donald Trump prepares to be formally nominated as the GOP’s candidate for president next week, the platform he will run on is taking shape. And in line with Trump’s approach, it aims to simultaneously satisfy hard-core abortion opponents and reassure more moderate swing voters. Meanwhile, the Federal Trade Commission takes on pharmacy benefits management firms. Shefali Luthra of The 19th News, Sandhya Raman of CQ Roll Call, and Jessie Hellmann of CQ Roll Call join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these stories and more. Also this week, Rovner interviews Jennifer Klein, director of the White House Gender Policy Council, about the Biden administration’s policies to ensure access to reproductive health care.

KFF Health News' 'What the Health?': Abortion Pill’s Legal Limbo Continues

August 17, 2023

A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market — rejecting a lower court’s decision to effectively cancel the drug’s FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court’s ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join KFF Health News’ chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

KFF Health News' 'What the Health?': The Confusing Fate of the Abortion Pill

April 13, 2023

The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

Filter Results